![]() |
PF-06840003
- 英文名称:PF-06840003
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11232
- cas:198474-05-4
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B11232 |
用途 | 科研检测 |
英文名称 | PF-06840003 |
包装规格 | 1MG |
CAS编号 | 198474-05-4 |
别名 | PF-06840003 |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by TLC;NMR (Conforms)
分子式:C12H9FN2O2
分子量:232.21
溶剂:DMSO (>25 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):IDO1 inhibitor
Function / Pharmacology:PF-06840003 (198474-05-4) is a potent (IC50 = 150 and 410 nM via two methods) and selective inhibitor of Indoleamine-2,3-dioxygenase (IDO1).1 In mice with syngeneic tumor grafts, it reduced intratumoral kynurenine levels by over 80%, inhibited tumor growth as monotherapy, and increased the efficacy of anti-PD-L1 therapy.2 PF-06840003 treatment combined with GM-CSF-secreting allogenic pancreatic tumor cell vaccine (GVAX) resulted in increased antitumor efficacy in a murine model of pancreatic ductal adenocarcinoma.3
分子式:C12H9FN2O2
分子量:232.21
溶剂:DMSO (>25 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):IDO1 inhibitor
Function / Pharmacology:PF-06840003 (198474-05-4) is a potent (IC50 = 150 and 410 nM via two methods) and selective inhibitor of Indoleamine-2,3-dioxygenase (IDO1).1 In mice with syngeneic tumor grafts, it reduced intratumoral kynurenine levels by over 80%, inhibited tumor growth as monotherapy, and increased the efficacy of anti-PD-L1 therapy.2 PF-06840003 treatment combined with GM-CSF-secreting allogenic pancreatic tumor cell vaccine (GVAX) resulted in increased antitumor efficacy in a murine model of pancreatic ductal adenocarcinoma.3